Compared with HCs, the expression of IL‐4 in the supernatant enhanced in the SLE‐MS group (34.74 ± 1.58 vs. 24.40 ± 1.04 pg/mL; p < 0.001). The gene discussed is IL4; the disease is myeloid sarcoma.